These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 27012864)

  • 1. Aberrant activation of CaMKIIγ accelerates chronic myeloid leukemia blast crisis.
    Gu Y; Zheng W; Zhang J; Gan X; Ma X; Meng Z; Chen T; Lu X; Wu Z; Huang W; Xu R
    Leukemia; 2016 Jun; 30(6):1282-9. PubMed ID: 27012864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of EVI1 transcription by the LEF1/β-catenin complex with p53-alteration in myeloid blast crisis of chronic myeloid leukemia.
    Manachai N; Saito Y; Nakahata S; Bahirvani AG; Osato M; Morishita K
    Biochem Biophys Res Commun; 2017 Jan; 482(4):994-1000. PubMed ID: 27908728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting of the MNK-eIF4E axis in blast crisis chronic myeloid leukemia inhibits leukemia stem cell function.
    Lim S; Saw TY; Zhang M; Janes MR; Nacro K; Hill J; Lim AQ; Chang CT; Fruman DA; Rizzieri DA; Tan SY; Fan H; Chuah CT; Ong ST
    Proc Natl Acad Sci U S A; 2013 Jun; 110(25):E2298-307. PubMed ID: 23737503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycogen synthase kinase 3beta missplicing contributes to leukemia stem cell generation.
    Abrahamsson AE; Geron I; Gotlib J; Dao KH; Barroga CF; Newton IG; Giles FJ; Durocher J; Creusot RS; Karimi M; Jones C; Zehnder JL; Keating A; Negrin RS; Weissman IL; Jamieson CH
    Proc Natl Acad Sci U S A; 2009 Mar; 106(10):3925-9. PubMed ID: 19237556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversion to an embryonic alternative splicing program enhances leukemia stem cell self-renewal.
    Holm F; Hellqvist E; Mason CN; Ali SA; Delos-Santos N; Barrett CL; Chun HJ; Minden MD; Moore RA; Marra MA; Runza V; Frazer KA; Sadarangani A; Jamieson CH
    Proc Natl Acad Sci U S A; 2015 Dec; 112(50):15444-9. PubMed ID: 26621726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of Selective Mitogen-Activated Protein Kinase Interacting Kinases 1 and 2 Inhibitors for the Treatment of Blast Crisis Leukemia.
    Yang H; Chennamaneni LR; Ho MWT; Ang SH; Tan ESW; Jeyaraj DA; Yeap YS; Liu B; Ong EH; Joy JK; Wee JLK; Kwek P; Retna P; Dinie N; Nguyen TTH; Tai SJ; Manoharan V; Pendharkar V; Low CB; Chew YS; Vuddagiri S; Sangthongpitag K; Choong ML; Lee MA; Kannan S; Verma CS; Poulsen A; Lim S; Chuah C; Ong TS; Hill J; Matter A; Nacro K
    J Med Chem; 2018 May; 61(10):4348-4369. PubMed ID: 29683667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic myeloid leukemia stem cells.
    Jamieson CH
    Hematology Am Soc Hematol Educ Program; 2008; ():436-42. PubMed ID: 19074122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imatinib and bortezomib induce the expression and distribution of anaphase-promoting complex adaptor protein Cdh1 in blast crisis of chronic myeloid leukemia.
    Wang Q; Zhou HS; Huang KK; Jiang XJ; Wu FQ; Cao R; Yin CX; Liao LB; Zheng ZX; He H; Lin R; Yi ZS; Xu D; Yang M; Meng FY
    Int J Oncol; 2012 Feb; 40(2):418-26. PubMed ID: 22002244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of BCR-ABL-Y177-mediated p27kip1 phosphorylation and cytoplasmic localization in enhanced proliferation of chronic myeloid leukemia progenitors.
    Chu S; McDonald T; Bhatia R
    Leukemia; 2010 Apr; 24(4):779-87. PubMed ID: 20200561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphocytic leukemia.
    Neviani P; Santhanam R; Oaks JJ; Eiring AM; Notari M; Blaser BW; Liu S; Trotta R; Muthusamy N; Gambacorti-Passerini C; Druker BJ; Cortes J; Marcucci G; Chen CS; Verrills NM; Roy DC; Caligiuri MA; Bloomfield CD; Byrd JC; Perrotti D
    J Clin Invest; 2007 Sep; 117(9):2408-21. PubMed ID: 17717597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic myeloid leukemia stem cell biology.
    Crews LA; Jamieson CH
    Curr Hematol Malig Rep; 2012 Jun; 7(2):125-32. PubMed ID: 22467334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Research advance on molecular genetics of CML blast crisis].
    Zhu HQ; Zhang S; Liu XL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):217-21. PubMed ID: 18315935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD150(-) Side Population Defines Leukemia Stem Cells in a BALB/c Mouse Model of CML and Is Depleted by Genetic Loss of SIRT1.
    Wang Z; Chen CC; Chen W
    Stem Cells; 2015 Dec; 33(12):3437-51. PubMed ID: 26466808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene therapy for BCR-ABL+ human CML with dual phosphorylation resistant p27Kip1 and stable RNA interference using an EBV vector.
    Sengupta A; Banerjee D; Chandra S; Banerjee S
    J Gene Med; 2006 Oct; 8(10):1251-61. PubMed ID: 16952195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CaMKIIγ regulates the viability and self-renewal of acute myeloid leukaemia stem-like cells by the Alox5/NF-κB pathway.
    Cheng JH; Zhang WJ; Zhu JF; Cui D; Song KD; Qiang P; Mei CZ; Nie ZC; Ding BS; Han Z; Ding ZE; Zheng WW
    Int J Lab Hematol; 2021 Aug; 43(4):699-706. PubMed ID: 33369192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone deacetylase inhibitor LAQ824 both lowers expression and promotes proteasomal degradation of Bcr-Abl and induces apoptosis of imatinib mesylate-sensitive or -refractory chronic myelogenous leukemia-blast crisis cells.
    Nimmanapalli R; Fuino L; Bali P; Gasparetto M; Glozak M; Tao J; Moscinski L; Smith C; Wu J; Jove R; Atadja P; Bhalla K
    Cancer Res; 2003 Aug; 63(16):5126-35. PubMed ID: 12941844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diverse mechanisms of mTOR activation in chronic and blastic phase of chronic myelogenous leukemia.
    Stoklosa T; Glodkowska-Mrowka E; Hoser G; Kielak M; Seferynska I; Wlodarski P
    Exp Hematol; 2013 May; 41(5):462-9. PubMed ID: 23395818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of expression of both miR-15/16 loci in CML transition to blast crisis.
    Lovat F; Gasparini P; Nigita G; Larkin K; Byrd JC; Minden MD; Andreeff M; Carter BZ; Croce CM
    Proc Natl Acad Sci U S A; 2021 Mar; 118(11):. PubMed ID: 33836616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphoid blast crisis of chronic myelogenous leukemia occurring more than 11 years after receiving an allogeneic bone marrow transplant for chronic myelogenous leukemia in myeloid blast crisis at onset.
    Fukuno K; Tsurumi H; Yamada T; Oyama M; Matsuyama T; Terakura S; Kodera Y; Moriwaki H
    Bone Marrow Transplant; 2003 Feb; 31(3):211-3. PubMed ID: 12621483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquired miR-142 deficit in leukemic stem cells suffices to drive chronic myeloid leukemia into blast crisis.
    Zhang B; Zhao D; Chen F; Frankhouser D; Wang H; Pathak KV; Dong L; Torres A; Garcia-Mansfield K; Zhang Y; Hoang DH; Chen MH; Tao S; Cho H; Liang Y; Perrotti D; Branciamore S; Rockne R; Wu X; Ghoda L; Li L; Jin J; Chen J; Yu J; Caligiuri MA; Kuo YH; Boldin M; Su R; Swiderski P; Kortylewski M; Pirrotte P; Nguyen LXT; Marcucci G
    Nat Commun; 2023 Sep; 14(1):5325. PubMed ID: 37658085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.